bioRxivCancer BiologyPreprint
Cross-species analysis reveals unique and shared roles of Sox9 and Sox10 (SOXE family) transcription factors in melanoma
Abstract
SOX9 and SOX10 are two highly similar transcription factors with nearly 100% identity at their DNA binding domains. Both transcription factors play key but distinct roles in neural crest cell fate specification and melanoma formation. High expression of SOX9 and SOX10 appear to be mutually exclusive, with high SOX10 characteristic of proliferative melanoma and high SOX9 characteristic of metastatic melanoma. To further elucidate the role of SOX9 in melanoma, we over-express SOX9 in a zebrafish melanoma model and a human melanoma cell line. Analysis of tumor onset, binding dynamics, and transcriptional identities supports the notion of SOX9 driving a more mesenchymal signature, which is important for metastasis. Additionally, we identified a potential mechanism of SOX9 down-regulation via analysis of a functional and recurrent non-coding variant in human melanoma. Altogether, our results present a dosage-dependent role of SOX9 and, likely, SOX10 in the melanoma lifespan.
- organism: zebrafish
- organism: human
- assay: proteomics
- assay: DNA methylation
- research focus: cell type annotation
- research focus: gene regulatory network inference
- research focus: differential expression
- approach: experimental assay
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Functional in vivo characterization of zebrafish sox10 enhancers in melanoma and neural crest
R. L. Cunningham, E. T. Kramer, … C. K. Kaufman·bioRxiv·Feb 6, 2020
- SOX10 and microRNAs: decoding their interplay in regulating melanoma plasticity
Xin Lai, Chunyan Luan, … Julio Vera·International Journal of CancerPeer-reviewed·Jun 3, 2025
- Mapping of the hSOX10 protein interactome in human melanoma
Catherine M Newsom-Stewart, Dhaval P. Bhatt, … Charles K. Kaufman·bioRxiv·Sep 3, 2025
- Specific SOX10 enhancer elements modulate phenotype plasticity and drug resistance in melanoma
Sophia K. DeGeorgia, Charles K. Kaufman·bioRxiv·Dec 12, 2024
- HaloPROTAC-mediated degradation reveals SOX10-dependent gene expression changes in melanoma cells
Ashleigh L. Purvis, Christine M. DeRosa, … Sarah A. Slavoff·bioRxiv·Oct 20, 2026
- p300 KAT regulates SOX10 stability and function in human melanoma
A. Waddell, N. Grbic, … R. M. Alani·bioRxiv·Feb 20, 2024